Amazon.com Widgets

Is the pharmaceutical industry in the United States given enough regulatory leeway for effective research?

  • Pharmaceutical Research is very effective

    The money and research that has been spent on pharmaceutical products such as medicine and the monetary value has equated to millions. Government spending has been very strong for research and facilities have been built in favor of stronger research over the years. Many people will always feel like there is more that can be done.

  • Yes, there is enough leeway.

    The companies that research and develop new drugs already have enough freedom in this research. If research is harmful towards anyone or anything, then that research should not be conducted. Often these drugs that they try to sell end up having terrible side affects as well, making the regulations not enough.

  • They are not.

    The pharmaceutical industry in the United States is not given enough regulatory leeway for effective research. There are a ton of strict regulations that are effect what they can do, and it is limiting what they can do. Other countries are passing the United States in medical research because of this.

  • Yes They Are

    I believe the pharmaceutical industry in the United States is given enough regulatory leeway for effective research. It certainly seems as though they have been quite successful given the regulations in the past and they have been able to release ample new medications. I do not believe we should move to deregulate them to aide in their research.

  • No, the FDA blocks too much.

    The FDA gets in the way of the pharmaceutical industry way too often and big pharma is often the ones who are blamed for it. While there is corruption in big pharma, it by no means matches the corruption and failures of the FDA as a whole. If the FDA would be revamped, so much would improve.


Leave a comment...
(Maximum 900 words)
No comments yet.